Vanda Pharmaceuticals, Inc. (VNDA) Reports Fourth Quarter 2012 and Full Year 2012 Results  
2/12/2013 6:25:01 AM

WASHINGTON, Feb. 12, 2013 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced financial and operational results for the fourth quarter and full year ended December 31, 2012.